表纸
市场调查报告书

单株抗体的全球市场

Monoclonal Antibodies

出版商 Global Industry Analysts, Inc. 商品编码 912648
出版日期 内容资讯 英文 462 Pages
商品交期: 最快1-2个工作天内
价格
单株抗体的全球市场 Monoclonal Antibodies
出版日期: 2020年09月01日内容资讯: 英文 462 Pages
简介

本报告提供全球单株抗体的市场相关分析,汇整整体市场规模的实际成果值·预测值,及主要推动及阻碍市场要素,不同症状·各原料·各用途及各企业的市场占有率趋势 (过去9年·今后8年份),今后的市场成长的方向性,各地区·主要国家的市场详细趋势等调查,主要企业的简介等资讯,为您概述为以下内容。

第1章 简介,分析方法·范围

第2章 摘要整理

  • 市场概要
    • 各企业的市场占有率结构 (最新值·预测值)
  • 代表性企业分析
  • 市场趋势与促进因素
  • 全球市场的未来展望
    • 市场规模·占有率趋势预测:各地区/各国
    • 不同症状 (感染疾病,癌症,微生物疾病等)
    • 各原料 (人体化抗体,人抗体,嵌合抗体,鼠标抗体)
    • 各用途 (诊断用,治疗用等)
      • 市场规模:各地区/各国 (过去9年·今后8年份)
      • 市场占有率:各地区/各国 (总计17年份)

第3章 市场分析

  • 各地区的市场分析
  • 美国
    • 市场基本资料
    • 各企业市场占有率
    • 单株抗体的市场规模 (实际成果值·预测值)
    • 不同症状的市场规模 (实际成果值·预测值)
    • 各原料的市场规模 (实际成果值·预测值)
  • 加拿大
  • 日本
  • 中国
  • 欧洲 (法国,德国,义大利,英国,西班牙,俄罗斯等)
  • 亚太地区 (澳洲,印度,韩国等)
  • 南美 (阿根廷,巴西,墨西哥等)
  • 中东 (伊朗,以色列,沙乌地阿拉伯,UAE等)
  • 非洲

第4章 企业

  • ABBOTT DIAGNOSTICS, INC. - CORE LABORATORY
  • ABBVIE
  • AMGEN
  • ASTRAZENECA PLC
  • BRISTOL-MYERS SQUIBB COMPANY
  • ELI LILLY AND COMPANY
  • F. HOFFMANN-LA ROCHE AG
  • JOHNSON & JOHNSON
  • MERCK & CO., INC.
  • NOVARTIS INTERNATIONAL AG

第5章 相关分析

目录
Product Code: MCP-3411

Global Monoclonal Antibodies Market to Reach $142.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Monoclonal Antibodies estimated at US$100.1 Billion in the year 2020, is projected to reach a revised size of US$142.2 Billion by 2027, growing at a CAGR of 5.1% over the analysis period 2020-2027. Inflammatory Disease, one of the segments analyzed in the report, is projected to record a 5.5% CAGR and reach US$44.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Cancer segment is readjusted to a revised 5.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $27.1 Billion, While China is Forecast to Grow at 7.9% CAGR

The Monoclonal Antibodies market in the U.S. is estimated at US$27.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$29.3 Billion by the year 2027 trailing a CAGR of 7.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 4.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Microbial Disease Segment to Record 4.2% CAGR

In the global Microbial Disease segment, USA, Canada, Japan, China and Europe will drive the 3.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$14.9 Billion in the year 2020 will reach a projected size of US$19.5 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$19 Billion by the year 2027, while Latin America will expand at a 5.1% CAGR through the analysis period. We bring years of research experience to this 15th edition of our report. The 462-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abbott Diagnostics, Inc. - Core Laboratory
  • AbbVie, Inc.
  • Amgen, Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis International AG

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Global Competitor Market Shares
    • Monoclonal Antibodies Competitor Market Share Scenario Worldwide (in %): 2019 &
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: Monoclonal Antibodies Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020
    • TABLE 2: Monoclonal Antibodies Global Retrospective Market Scenario in US$ Million by Region/Country: 2012
    • TABLE 3: Monoclonal Antibodies Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS
    • TABLE 4: Inflammatory Disease (Indication) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 5: Inflammatory Disease (Indication) Historic Market Analysis by Region/Country in US$ Million: 2012 to
    • TABLE 6: Inflammatory Disease (Indication) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS
    • TABLE 7: Cancer (Indication) Potential Growth Markets Worldwide in US$ Million: 2020 to
    • TABLE 8: Cancer (Indication) Historic Market Perspective by Region/Country in US$ Million: 2012 to
    • TABLE 9: Cancer (Indication) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS
    • TABLE 10: Microbial Disease (Indication) Geographic Market Spread Worldwide in US$ Million: 2020 to
    • TABLE 11: Microbial Disease (Indication) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to
    • TABLE 12: Microbial Disease (Indication) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 13: Other Indications (Indication) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to
    • TABLE 14: Other Indications (Indication) Market Historic Review by Region/Country in US$ Million: 2012 to
    • TABLE 15: Other Indications (Indication) Market Share Breakdown by Region/Country: 2012 VS 2020 VS
    • TABLE 16: Humanized (Source) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 17: Humanized (Source) Historic Market Analysis by Region/Country in US$ Million: 2012 to
    • TABLE 18: Humanized (Source) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 19: Human (Source) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to
    • TABLE 20: Human (Source) Market Worldwide Historic Review by Region/Country in US$ Million: 2012 to
    • TABLE 21: Human (Source) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS
    • TABLE 22: Chimeric (Source) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to
    • TABLE 23: Chimeric (Source) Global Historic Demand in US$ Million by Region/Country: 2012 to
    • TABLE 24: Chimeric (Source) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 25: Murine (Source) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 26: Murine (Source) Historic Market Analysis by Region/Country in US$ Million: 2012 to
    • TABLE 27: Murine (Source) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS
    • TABLE 28: Diagnostic (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2020
    • TABLE 29: Diagnostic (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2012
    • TABLE 30: Diagnostic (Application) Market Share Breakdown by Region/Country: 2012 VS 2020 VS
    • TABLE 31: Therapeutic (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2020
    • TABLE 32: Therapeutic (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012
    • TABLE 33: Therapeutic (Application) Share Breakdown Review by Region/Country: 2012 VS 2020 VS
    • TABLE 34: Other Applications (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020
    • TABLE 35: Other Applications (Application) Global Historic Analysis in US$ Million by Region/Country: 2012
    • TABLE 36: Other Applications (Application) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Monoclonal Antibodies Market Share (in %) by Company: 2019 &
    • Market Analytics
    • TABLE 37: United States Monoclonal Antibodies Market Estimates and Projections in US$ Million by Indication: 2020 to
    • TABLE 38: Monoclonal Antibodies Market in the United States by Indication: A Historic Review in US$ Million for 2012
    • TABLE 39: United States Monoclonal Antibodies Market Share Breakdown by Indication: 2012 VS 2020 VS
    • TABLE 40: United States Monoclonal Antibodies Market Estimates and Projections in US$ Million by Source: 2020 to
    • TABLE 41: Monoclonal Antibodies Market in the United States by Source: A Historic Review in US$ Million for 2012
    • TABLE 42: United States Monoclonal Antibodies Market Share Breakdown by Source: 2012 VS 2020 VS
    • TABLE 43: United States Monoclonal Antibodies Latent Demand Forecasts in US$ Million by Application: 2020 to
    • TABLE 44: Monoclonal Antibodies Historic Demand Patterns in the United States by Application in US$ Million for 2012
    • TABLE 45: Monoclonal Antibodies Market Share Breakdown in the United States by Application: 2012 VS 2020 VS
  • CANADA
    • TABLE 46: Canadian Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Indication: 2020 to
    • TABLE 47: Canadian Monoclonal Antibodies Historic Market Review by Indication in US$ Million: 2012
    • TABLE 48: Monoclonal Antibodies Market in Canada: Percentage Share Breakdown of Sales by Indication for 2012, 2020, and
    • TABLE 49: Canadian Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Source: 2020 to
    • TABLE 50: Canadian Monoclonal Antibodies Historic Market Review by Source in US$ Million: 2012
    • TABLE 51: Monoclonal Antibodies Market in Canada: Percentage Share Breakdown of Sales by Source for 2012, 2020, and
    • TABLE 52: Canadian Monoclonal Antibodies Market Quantitative Demand Analysis in US$ Million by Application: 2020 to
    • TABLE 53: Monoclonal Antibodies Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2012
    • TABLE 54: Canadian Monoclonal Antibodies Market Share Analysis by Application: 2012 VS 2020 VS
  • JAPAN
    • TABLE 55: Japanese Market for Monoclonal Antibodies: Annual Sales Estimates and Projections in US$ Million by Indication for the Period 2020
    • TABLE 56: Monoclonal Antibodies Market in Japan: Historic Sales Analysis in US$ Million by Indication for the Period 2012
    • TABLE 57: Japanese Monoclonal Antibodies Market Share Analysis by Indication: 2012 VS 2020 VS
    • TABLE 58: Japanese Market for Monoclonal Antibodies: Annual Sales Estimates and Projections in US$ Million by Source for the Period 2020
    • TABLE 59: Monoclonal Antibodies Market in Japan: Historic Sales Analysis in US$ Million by Source for the Period 2012
    • TABLE 60: Japanese Monoclonal Antibodies Market Share Analysis by Source: 2012 VS 2020 VS
    • TABLE 61: Japanese Demand Estimates and Forecasts for Monoclonal Antibodies in US$ Million by Application: 2020 to
    • TABLE 62: Japanese Monoclonal Antibodies Market in US$ Million by Application: 2012
    • TABLE 63: Monoclonal Antibodies Market Share Shift in Japan by Application: 2012 VS 2020 VS
  • CHINA
    • TABLE 64: Chinese Monoclonal Antibodies Market Growth Prospects in US$ Million by Indication for the Period 2020
    • TABLE 65: Monoclonal Antibodies Historic Market Analysis in China in US$ Million by Indication: 2012
    • TABLE 66: Chinese Monoclonal Antibodies Market by Indication: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 67: Chinese Monoclonal Antibodies Market Growth Prospects in US$ Million by Source for the Period 2020
    • TABLE 68: Monoclonal Antibodies Historic Market Analysis in China in US$ Million by Source: 2012
    • TABLE 69: Chinese Monoclonal Antibodies Market by Source: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 70: Chinese Demand for Monoclonal Antibodies in US$ Million by Application: 2020 to
    • TABLE 71: Monoclonal Antibodies Market Review in China in US$ Million by Application: 2012
    • TABLE 72: Chinese Monoclonal Antibodies Market Share Breakdown by Application: 2012 VS 2020 VS
  • EUROPE
    • Market Facts & Figures
    • European Monoclonal Antibodies Market: Competitor Market Share Scenario (in %) for 2019 &
    • Market Analytics
    • TABLE 73: European Monoclonal Antibodies Market Demand Scenario in US$ Million by Region/Country: 2020
    • TABLE 74: Monoclonal Antibodies Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012
    • TABLE 75: European Monoclonal Antibodies Market Share Shift by Region/Country: 2012 VS 2020 VS
    • TABLE 76: European Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Indication: 2020
    • TABLE 77: Monoclonal Antibodies Market in Europe in US$ Million by Indication: A Historic Review for the Period 2012
    • TABLE 78: European Monoclonal Antibodies Market Share Breakdown by Indication: 2012 VS 2020 VS
    • TABLE 79: European Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Source: 2020
    • TABLE 80: Monoclonal Antibodies Market in Europe in US$ Million by Source: A Historic Review for the Period 2012
    • TABLE 81: European Monoclonal Antibodies Market Share Breakdown by Source: 2012 VS 2020 VS
    • TABLE 82: European Monoclonal Antibodies Addressable Market Opportunity in US$ Million by Application: 2020
    • TABLE 83: Monoclonal Antibodies Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012
    • TABLE 84: European Monoclonal Antibodies Market Share Analysis by Application: 2012 VS 2020 VS
  • FRANCE
    • TABLE 85: Monoclonal Antibodies Market in France by Indication: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 86: French Monoclonal Antibodies Historic Market Scenario in US$ Million by Indication: 2012
    • TABLE 87: French Monoclonal Antibodies Market Share Analysis by Indication: 2012 VS 2020 VS
    • TABLE 88: Monoclonal Antibodies Market in France by Source: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 89: French Monoclonal Antibodies Historic Market Scenario in US$ Million by Source: 2012
    • TABLE 90: French Monoclonal Antibodies Market Share Analysis by Source: 2012 VS 2020 VS
    • TABLE 91: Monoclonal Antibodies Quantitative Demand Analysis in France in US$ Million by Application: 2020
    • TABLE 92: French Monoclonal Antibodies Historic Market Review in US$ Million by Application: 2012
    • TABLE 93: French Monoclonal Antibodies Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and
  • GERMANY
    • TABLE 94: Monoclonal Antibodies Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2020
    • TABLE 95: German Monoclonal Antibodies Historic Market Analysis in US$ Million by Indication: 2012
    • TABLE 96: German Monoclonal Antibodies Market Share Breakdown by Indication: 2012 VS 2020 VS
    • TABLE 97: Monoclonal Antibodies Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Source for the Period 2020
    • TABLE 98: German Monoclonal Antibodies Historic Market Analysis in US$ Million by Source: 2012
    • TABLE 99: German Monoclonal Antibodies Market Share Breakdown by Source: 2012 VS 2020 VS
    • TABLE 100: Monoclonal Antibodies Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020
    • TABLE 101: German Monoclonal Antibodies Market in Retrospect in US$ Million by Application: 2012
    • TABLE 102: Monoclonal Antibodies Market Share Distribution in Germany by Application: 2012 VS 2020 VS
  • ITALY
    • TABLE 103: Italian Monoclonal Antibodies Market Growth Prospects in US$ Million by Indication for the Period 2020
    • TABLE 104: Monoclonal Antibodies Historic Market Analysis in Italy in US$ Million by Indication: 2012
    • TABLE 105: Italian Monoclonal Antibodies Market by Indication: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 106: Italian Monoclonal Antibodies Market Growth Prospects in US$ Million by Source for the Period 2020
    • TABLE 107: Monoclonal Antibodies Historic Market Analysis in Italy in US$ Million by Source: 2012
    • TABLE 108: Italian Monoclonal Antibodies Market by Source: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 109: Italian Demand for Monoclonal Antibodies in US$ Million by Application: 2020 to
    • TABLE 110: Monoclonal Antibodies Market Review in Italy in US$ Million by Application: 2012
    • TABLE 111: Italian Monoclonal Antibodies Market Share Breakdown by Application: 2012 VS 2020 VS
  • UNITED KINGDOM
    • TABLE 112: United Kingdom Market for Monoclonal Antibodies: Annual Sales Estimates and Projections in US$ Million by Indication for the Period 2020
    • TABLE 113: Monoclonal Antibodies Market in the United Kingdom: Historic Sales Analysis in US$ Million by Indication for the Period 2012
    • TABLE 114: United Kingdom Monoclonal Antibodies Market Share Analysis by Indication: 2012 VS 2020 VS
    • TABLE 115: United Kingdom Market for Monoclonal Antibodies: Annual Sales Estimates and Projections in US$ Million by Source for the Period 2020
    • TABLE 116: Monoclonal Antibodies Market in the United Kingdom: Historic Sales Analysis in US$ Million by Source for the Period 2012
    • TABLE 117: United Kingdom Monoclonal Antibodies Market Share Analysis by Source: 2012 VS 2020 VS
    • TABLE 118: United Kingdom Demand Estimates and Forecasts for Monoclonal Antibodies in US$ Million by Application: 2020 to
    • TABLE 119: United Kingdom Monoclonal Antibodies Market in US$ Million by Application: 2012
    • TABLE 120: Monoclonal Antibodies Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS
  • SPAIN
    • TABLE 121: Spanish Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Indication: 2020 to
    • TABLE 122: Spanish Monoclonal Antibodies Historic Market Review by Indication in US$ Million: 2012
    • TABLE 123: Monoclonal Antibodies Market in Spain: Percentage Share Breakdown of Sales by Indication for 2012, 2020, and
    • TABLE 124: Spanish Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Source: 2020 to
    • TABLE 125: Spanish Monoclonal Antibodies Historic Market Review by Source in US$ Million: 2012
    • TABLE 126: Monoclonal Antibodies Market in Spain: Percentage Share Breakdown of Sales by Source for 2012, 2020, and
    • TABLE 127: Spanish Monoclonal Antibodies Market Quantitative Demand Analysis in US$ Million by Application: 2020 to
    • TABLE 128: Monoclonal Antibodies Market in Spain: Summarization of Historic Demand Patterns in US$ Million by Application for 2012
    • TABLE 129: Spanish Monoclonal Antibodies Market Share Analysis by Application: 2012 VS 2020 VS
  • RUSSIA
    • TABLE 130: Russian Monoclonal Antibodies Market Estimates and Projections in US$ Million by Indication: 2020 to
    • TABLE 131: Monoclonal Antibodies Market in Russia by Indication: A Historic Review in US$ Million for 2012
    • TABLE 132: Russian Monoclonal Antibodies Market Share Breakdown by Indication: 2012 VS 2020 VS
    • TABLE 133: Russian Monoclonal Antibodies Market Estimates and Projections in US$ Million by Source: 2020 to
    • TABLE 134: Monoclonal Antibodies Market in Russia by Source: A Historic Review in US$ Million for 2012
    • TABLE 135: Russian Monoclonal Antibodies Market Share Breakdown by Source: 2012 VS 2020 VS
    • TABLE 136: Russian Monoclonal Antibodies Latent Demand Forecasts in US$ Million by Application: 2020 to
    • TABLE 137: Monoclonal Antibodies Historic Demand Patterns in Russia by Application in US$ Million for 2012
    • TABLE 138: Monoclonal Antibodies Market Share Breakdown in Russia by Application: 2012 VS 2020 VS
  • REST OF EUROPE
    • TABLE 139: Rest of Europe Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Indication: 2020
    • TABLE 140: Monoclonal Antibodies Market in Rest of Europe in US$ Million by Indication: A Historic Review for the Period 2012
    • TABLE 141: Rest of Europe Monoclonal Antibodies Market Share Breakdown by Indication: 2012 VS 2020 VS
    • TABLE 142: Rest of Europe Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Source: 2020
    • TABLE 143: Monoclonal Antibodies Market in Rest of Europe in US$ Million by Source: A Historic Review for the Period 2012
    • TABLE 144: Rest of Europe Monoclonal Antibodies Market Share Breakdown by Source: 2012 VS 2020 VS
    • TABLE 145: Rest of Europe Monoclonal Antibodies Addressable Market Opportunity in US$ Million by Application: 2020
    • TABLE 146: Monoclonal Antibodies Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012
    • TABLE 147: Rest of Europe Monoclonal Antibodies Market Share Analysis by Application: 2012 VS 2020 VS
  • ASIA-PACIFIC
    • TABLE 148: Asia-Pacific Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Region/Country: 2020
    • TABLE 149: Monoclonal Antibodies Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012
    • TABLE 150: Asia-Pacific Monoclonal Antibodies Market Share Analysis by Region/Country: 2012 VS 2020 VS
    • TABLE 151: Monoclonal Antibodies Market in Asia-Pacific by Indication: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 152: Asia-Pacific Monoclonal Antibodies Historic Market Scenario in US$ Million by Indication: 2012
    • TABLE 153: Asia-Pacific Monoclonal Antibodies Market Share Analysis by Indication: 2012 VS 2020 VS
    • TABLE 154: Monoclonal Antibodies Market in Asia-Pacific by Source: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 155: Asia-Pacific Monoclonal Antibodies Historic Market Scenario in US$ Million by Source: 2012
    • TABLE 156: Asia-Pacific Monoclonal Antibodies Market Share Analysis by Source: 2012 VS 2020 VS
    • TABLE 157: Monoclonal Antibodies Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020
    • TABLE 158: Asia-Pacific Monoclonal Antibodies Historic Market Review in US$ Million by Application: 2012
    • TABLE 159: Asia-Pacific Monoclonal Antibodies Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and
  • AUSTRALIA
    • TABLE 160: Monoclonal Antibodies Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2020
    • TABLE 161: Australian Monoclonal Antibodies Historic Market Analysis in US$ Million by Indication: 2012
    • TABLE 162: Australian Monoclonal Antibodies Market Share Breakdown by Indication: 2012 VS 2020 VS
    • TABLE 163: Monoclonal Antibodies Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Source for the Period 2020
    • TABLE 164: Australian Monoclonal Antibodies Historic Market Analysis in US$ Million by Source: 2012
    • TABLE 165: Australian Monoclonal Antibodies Market Share Breakdown by Source: 2012 VS 2020 VS
    • TABLE 166: Monoclonal Antibodies Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020
    • TABLE 167: Australian Monoclonal Antibodies Market in Retrospect in US$ Million by Application: 2012
    • TABLE 168: Monoclonal Antibodies Market Share Distribution in Australia by Application: 2012 VS 2020 VS
  • INDIA
    • TABLE 169: Indian Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Indication: 2020 to
    • TABLE 170: Indian Monoclonal Antibodies Historic Market Review by Indication in US$ Million: 2012
    • TABLE 171: Monoclonal Antibodies Market in India: Percentage Share Breakdown of Sales by Indication for 2012, 2020, and
    • TABLE 172: Indian Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Source: 2020 to
    • TABLE 173: Indian Monoclonal Antibodies Historic Market Review by Source in US$ Million: 2012
    • TABLE 174: Monoclonal Antibodies Market in India: Percentage Share Breakdown of Sales by Source for 2012, 2020, and
    • TABLE 175: Indian Monoclonal Antibodies Market Quantitative Demand Analysis in US$ Million by Application: 2020 to
    • TABLE 176: Monoclonal Antibodies Market in India: Summarization of Historic Demand Patterns in US$ Million by Application for 2012
    • TABLE 177: Indian Monoclonal Antibodies Market Share Analysis by Application: 2012 VS 2020 VS
  • SOUTH KOREA
    • TABLE 178: Monoclonal Antibodies Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2020
    • TABLE 179: South Korean Monoclonal Antibodies Historic Market Analysis in US$ Million by Indication: 2012
    • TABLE 180: Monoclonal Antibodies Market Share Distribution in South Korea by Indication: 2012 VS 2020 VS
    • TABLE 181: Monoclonal Antibodies Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Source for the Period 2020
    • TABLE 182: South Korean Monoclonal Antibodies Historic Market Analysis in US$ Million by Source: 2012
    • TABLE 183: Monoclonal Antibodies Market Share Distribution in South Korea by Source: 2012 VS 2020 VS
    • TABLE 184: Monoclonal Antibodies Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2020
    • TABLE 185: South Korean Monoclonal Antibodies Historic Market Analysis in US$ Million by Application: 2012
    • TABLE 186: Monoclonal Antibodies Market Share Distribution in South Korea by Application: 2012 VS 2020 VS
  • REST OF ASIA-PACIFIC
    • TABLE 187: Rest of Asia-Pacific Market for Monoclonal Antibodies: Annual Sales Estimates and Projections in US$ Million by Indication for the Period 2020
    • TABLE 188: Monoclonal Antibodies Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Indication for the Period 2012
    • TABLE 189: Rest of Asia-Pacific Monoclonal Antibodies Market Share Analysis by Indication: 2012 VS 2020 VS
    • TABLE 190: Rest of Asia-Pacific Market for Monoclonal Antibodies: Annual Sales Estimates and Projections in US$ Million by Source for the Period 2020
    • TABLE 191: Monoclonal Antibodies Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Source for the Period 2012
    • TABLE 192: Rest of Asia-Pacific Monoclonal Antibodies Market Share Analysis by Source: 2012 VS 2020 VS
    • TABLE 193: Rest of Asia-Pacific Demand Estimates and Forecasts for Monoclonal Antibodies in US$ Million by Application: 2020 to
    • TABLE 194: Rest of Asia-Pacific Monoclonal Antibodies Market in US$ Million by Application: 2012
    • TABLE 195: Monoclonal Antibodies Market Share Shift in Rest of Asia-Pacific by Application: 2012 VS 2020 VS
  • LATIN AMERICA
    • TABLE 196: Latin American Monoclonal Antibodies Market Trends by Region/Country in US$ Million: 2020
    • TABLE 197: Monoclonal Antibodies Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012
    • TABLE 198: Latin American Monoclonal Antibodies Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and
    • TABLE 199: Latin American Monoclonal Antibodies Market Growth Prospects in US$ Million by Indication for the Period 2020
    • TABLE 200: Monoclonal Antibodies Historic Market Analysis in Latin America in US$ Million by Indication: 2012
    • TABLE 201: Latin American Monoclonal Antibodies Market by Indication: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 202: Latin American Monoclonal Antibodies Market Growth Prospects in US$ Million by Source for the Period 2020
    • TABLE 203: Monoclonal Antibodies Historic Market Analysis in Latin America in US$ Million by Source: 2012
    • TABLE 204: Latin American Monoclonal Antibodies Market by Source: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 205: Latin American Demand for Monoclonal Antibodies in US$ Million by Application: 2020 to
    • TABLE 206: Monoclonal Antibodies Market Review in Latin America in US$ Million by Application: 2012
    • TABLE 207: Latin American Monoclonal Antibodies Market Share Breakdown by Application: 2012 VS 2020 VS
  • ARGENTINA
    • TABLE 208: Argentinean Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Indication: 2020
    • TABLE 209: Monoclonal Antibodies Market in Argentina in US$ Million by Indication: A Historic Review for the Period 2012
    • TABLE 210: Argentinean Monoclonal Antibodies Market Share Breakdown by Indication: 2012 VS 2020 VS
    • TABLE 211: Argentinean Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Source: 2020
    • TABLE 212: Monoclonal Antibodies Market in Argentina in US$ Million by Source: A Historic Review for the Period 2012
    • TABLE 213: Argentinean Monoclonal Antibodies Market Share Breakdown by Source: 2012 VS 2020 VS
    • TABLE 214: Argentinean Monoclonal Antibodies Addressable Market Opportunity in US$ Million by Application: 2020
    • TABLE 215: Monoclonal Antibodies Market in Argentina: Summarization of Historic Demand in US$ Million by Application for the Period 2012
    • TABLE 216: Argentinean Monoclonal Antibodies Market Share Analysis by Application: 2012 VS 2020 VS
  • BRAZIL
    • TABLE 217: Monoclonal Antibodies Market in Brazil by Indication: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 218: Brazilian Monoclonal Antibodies Historic Market Scenario in US$ Million by Indication: 2012
    • TABLE 219: Brazilian Monoclonal Antibodies Market Share Analysis by Indication: 2012 VS 2020 VS
    • TABLE 220: Monoclonal Antibodies Market in Brazil by Source: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 221: Brazilian Monoclonal Antibodies Historic Market Scenario in US$ Million by Source: 2012
    • TABLE 222: Brazilian Monoclonal Antibodies Market Share Analysis by Source: 2012 VS 2020 VS
    • TABLE 223: Monoclonal Antibodies Quantitative Demand Analysis in Brazil in US$ Million by Application: 2020
    • TABLE 224: Brazilian Monoclonal Antibodies Historic Market Review in US$ Million by Application: 2012
    • TABLE 225: Brazilian Monoclonal Antibodies Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and
  • MEXICO
    • TABLE 226: Monoclonal Antibodies Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2020
    • TABLE 227: Mexican Monoclonal Antibodies Historic Market Analysis in US$ Million by Indication: 2012
    • TABLE 228: Mexican Monoclonal Antibodies Market Share Breakdown by Indication: 2012 VS 2020 VS
    • TABLE 229: Monoclonal Antibodies Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Source for the Period 2020
    • TABLE 230: Mexican Monoclonal Antibodies Historic Market Analysis in US$ Million by Source: 2012
    • TABLE 231: Mexican Monoclonal Antibodies Market Share Breakdown by Source: 2012 VS 2020 VS
    • TABLE 232: Monoclonal Antibodies Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020
    • TABLE 233: Mexican Monoclonal Antibodies Market in Retrospect in US$ Million by Application: 2012
    • TABLE 234: Monoclonal Antibodies Market Share Distribution in Mexico by Application: 2012 VS 2020 VS
  • REST OF LATIN AMERICA
    • TABLE 235: Rest of Latin America Monoclonal Antibodies Market Estimates and Projections in US$ Million by Indication: 2020 to
    • TABLE 236: Monoclonal Antibodies Market in Rest of Latin America by Indication: A Historic Review in US$ Million for 2012
    • TABLE 237: Rest of Latin America Monoclonal Antibodies Market Share Breakdown by Indication: 2012 VS 2020 VS
    • TABLE 238: Rest of Latin America Monoclonal Antibodies Market Estimates and Projections in US$ Million by Source: 2020 to
    • TABLE 239: Monoclonal Antibodies Market in Rest of Latin America by Source: A Historic Review in US$ Million for 2012
    • TABLE 240: Rest of Latin America Monoclonal Antibodies Market Share Breakdown by Source: 2012 VS 2020 VS
    • TABLE 241: Rest of Latin America Monoclonal Antibodies Latent Demand Forecasts in US$ Million by Application: 2020 to
    • TABLE 242: Monoclonal Antibodies Historic Demand Patterns in Rest of Latin America by Application in US$ Million for 2012
    • TABLE 243: Monoclonal Antibodies Market Share Breakdown in Rest of Latin America by Application: 2012 VS 2020 VS
  • MIDDLE EAST
    • TABLE 244: The Middle East Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Region/Country: 2020
    • TABLE 245: Monoclonal Antibodies Market in the Middle East by Region/Country in US$ Million: 2012
    • TABLE 246: The Middle East Monoclonal Antibodies Market Share Breakdown by Region/Country: 2012, 2020, and
    • TABLE 247: The Middle East Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Indication: 2020 to
    • TABLE 248: The Middle East Monoclonal Antibodies Historic Market by Indication in US$ Million: 2012
    • TABLE 249: Monoclonal Antibodies Market in the Middle East: Percentage Share Breakdown of Sales by Indication for 2012,2020, and
    • TABLE 250: The Middle East Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Source: 2020 to
    • TABLE 251: The Middle East Monoclonal Antibodies Historic Market by Source in US$ Million: 2012
    • TABLE 252: Monoclonal Antibodies Market in the Middle East: Percentage Share Breakdown of Sales by Source for 2012,2020, and
    • TABLE 253: The Middle East Monoclonal Antibodies Market Quantitative Demand Analysis in US$ Million by Application: 2020 to
    • TABLE 254: Monoclonal Antibodies Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by Application for 2012
    • TABLE 255: The Middle East Monoclonal Antibodies Market Share Analysis by Application: 2012 VS 2020 VS
  • IRAN
    • TABLE 256: Iranian Market for Monoclonal Antibodies: Annual Sales Estimates and Projections in US$ Million by Indication for the Period 2020
    • TABLE 257: Monoclonal Antibodies Market in Iran: Historic Sales Analysis in US$ Million by Indication for the Period 2012
    • TABLE 258: Iranian Monoclonal Antibodies Market Share Analysis by Indication: 2012 VS 2020 VS
    • TABLE 259: Iranian Market for Monoclonal Antibodies: Annual Sales Estimates and Projections in US$ Million by Source for the Period 2020
    • TABLE 260: Monoclonal Antibodies Market in Iran: Historic Sales Analysis in US$ Million by Source for the Period 2012
    • TABLE 261: Iranian Monoclonal Antibodies Market Share Analysis by Source: 2012 VS 2020 VS
    • TABLE 262: Iranian Demand Estimates and Forecasts for Monoclonal Antibodies in US$ Million by Application: 2020 to
    • TABLE 263: Iranian Monoclonal Antibodies Market in US$ Million by Application: 2012
    • TABLE 264: Monoclonal Antibodies Market Share Shift in Iran by Application: 2012 VS 2020 VS
  • ISRAEL
    • TABLE 265: Israeli Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Indication: 2020
    • TABLE 266: Monoclonal Antibodies Market in Israel in US$ Million by Indication: A Historic Review for the Period 2012
    • TABLE 267: Israeli Monoclonal Antibodies Market Share Breakdown by Indication: 2012 VS 2020 VS
    • TABLE 268: Israeli Monoclonal Antibodies Market Estimates and Forecasts in US$ Million by Source: 2020
    • TABLE 269: Monoclonal Antibodies Market in Israel in US$ Million by Source: A Historic Review for the Period 2012
    • TABLE 270: Israeli Monoclonal Antibodies Market Share Breakdown by Source: 2012 VS 2020 VS
    • TABLE 271: Israeli Monoclonal Antibodies Addressable Market Opportunity in US$ Million by Application: 2020
    • TABLE 272: Monoclonal Antibodies Market in Israel: Summarization of Historic Demand in US$ Million by Application for the Period 2012
    • TABLE 273: Israeli Monoclonal Antibodies Market Share Analysis by Application: 2012 VS 2020 VS
  • SAUDI ARABIA
    • TABLE 274: Saudi Arabian Monoclonal Antibodies Market Growth Prospects in US$ Million by Indication for the Period 2020
    • TABLE 275: Monoclonal Antibodies Historic Market Analysis in Saudi Arabia in US$ Million by Indication: 2012
    • TABLE 276: Saudi Arabian Monoclonal Antibodies Market by Indication: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 277: Saudi Arabian Monoclonal Antibodies Market Growth Prospects in US$ Million by Source for the Period 2020
    • TABLE 278: Monoclonal Antibodies Historic Market Analysis in Saudi Arabia in US$ Million by Source: 2012
    • TABLE 279: Saudi Arabian Monoclonal Antibodies Market by Source: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 280: Saudi Arabian Demand for Monoclonal Antibodies in US$ Million by Application: 2020 to
    • TABLE 281: Monoclonal Antibodies Market Review in Saudi Arabia in US$ Million by Application: 2012
    • TABLE 282: Saudi Arabian Monoclonal Antibodies Market Share Breakdown by Application: 2012 VS 2020 VS
  • UNITED ARAB EMIRATES
    • TABLE 283: Monoclonal Antibodies Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2020
    • TABLE 284: United Arab Emirates Monoclonal Antibodies Historic Market Analysis in US$ Million by Indication: 2012
    • TABLE 285: Monoclonal Antibodies Market Share Distribution in United Arab Emirates by Indication: 2012 VS 2020 VS
    • TABLE 286: Monoclonal Antibodies Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Source for the Period 2020
    • TABLE 287: United Arab Emirates Monoclonal Antibodies Historic Market Analysis in US$ Million by Source: 2012
    • TABLE 288: Monoclonal Antibodies Market Share Distribution in United Arab Emirates by Source: 2012 VS 2020 VS
    • TABLE 289: Monoclonal Antibodies Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2020
    • TABLE 290: United Arab Emirates Monoclonal Antibodies Historic Market Analysis in US$ Million by Application: 2012
    • TABLE 291: Monoclonal Antibodies Market Share Distribution in United Arab Emirates by Application: 2012 VS 2020 VS
  • REST OF MIDDLE EAST
    • TABLE 292: Monoclonal Antibodies Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2020
    • TABLE 293: Rest of Middle East Monoclonal Antibodies Historic Market Analysis in US$ Million by Indication: 2012
    • TABLE 294: Rest of Middle East Monoclonal Antibodies Market Share Breakdown by Indication: 2012 VS 2020 VS
    • TABLE 295: Monoclonal Antibodies Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Source for the Period 2020
    • TABLE 296: Rest of Middle East Monoclonal Antibodies Historic Market Analysis in US$ Million by Source: 2012
    • TABLE 297: Rest of Middle East Monoclonal Antibodies Market Share Breakdown by Source: 2012 VS 2020 VS
    • TABLE 298: Monoclonal Antibodies Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020
    • TABLE 299: Rest of Middle East Monoclonal Antibodies Market in Retrospect in US$ Million by Application: 2012
    • TABLE 300: Monoclonal Antibodies Market Share Distribution in Rest of Middle East by Application: 2012 VS 2020 VS
  • AFRICA
    • TABLE 301: African Monoclonal Antibodies Market Estimates and Projections in US$ Million by Indication: 2020 to
    • TABLE 302: Monoclonal Antibodies Market in Africa by Indication: A Historic Review in US$ Million for 2012
    • TABLE 303: African Monoclonal Antibodies Market Share Breakdown by Indication: 2012 VS 2020 VS
    • TABLE 304: African Monoclonal Antibodies Market Estimates and Projections in US$ Million by Source: 2020 to
    • TABLE 305: Monoclonal Antibodies Market in Africa by Source: A Historic Review in US$ Million for 2012
    • TABLE 306: African Monoclonal Antibodies Market Share Breakdown by Source: 2012 VS 2020 VS
    • TABLE 307: African Monoclonal Antibodies Latent Demand Forecasts in US$ Million by Application: 2020 to
    • TABLE 308: Monoclonal Antibodies Historic Demand Patterns in Africa by Application in US$ Million for 2012
    • TABLE 309: Monoclonal Antibodies Market Share Breakdown in Africa by Application: 2012 VS 2020 VS

IV. COMPETITION

  • Total Companies Profiled: 123